Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,674 Jan 1 – Oct 25, 2026
- Disclosed funding
- $339.4B 3661 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A AutireCompany profile Provides cloud-based software to support CPA firms performing employee benefit plan audits Provides cloud-based software to support CPA firms performing employee benefit plan audits | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| R Provides AI-enabled renovation financing platform for homeowners | $22M | Series B | Fintech | United States | Investors | |
| b Develops an AI-powered bioproduction platform for industrial ingredients | €7M | Seed | Biotech | France | Investors | |
| G GroundhawkCompany profile Provides real-time AI-powered 3D capture for underground infrastructure mapping and documentation Provides real-time AI-powered 3D capture for underground infrastructure mapping and documentation | €2M | Seed | Proptech | Finland | Investors | |
| PM Polares MedicalCompany profile Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation | $50M | Series CSeries C+ | Healthtech | Switzerland | Investors | |
| I Provides data-driven decision-making for wellness industry practices | $5M | Pre-SeedPre-seed | Consumer | United States | Investors | |
| K Provides AI-powered, Epic-based virtual care solution for health systems | $27.4M | Series B | Healthtech | United States | Investors | |
AntiverseCompany profile Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing. Antiverse designs therapeutic antibodies for difficult drug targets using generative AI, engineered cell lines and in-house laboratory testing. | $9.3M | Series A | Healthtech | United Kingdom | Investors | |
| B Develops AI platform for targeted crop protection solutions | $3.8M | Seed | Agritech | United Kingdom | Investors | |
| A ArmorCodeCompany profile Provides unified exposure management for AI security governance and life cycle management Provides unified exposure management for AI security governance and life cycle management | $16M | Series B | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds8led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →